NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/06/2026
Voltar para busca
Dado oficial do USPTO
ACAZEN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
05/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
21/11/2019
Data de registro
26/01/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/01/2021
Última transação
05/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
25
Localização do titular
CH
Examinador
EISNACH, MICHAEL PATRICK
Unidade examinadora
L40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Alpinia Institute for Life Sciences AG
Alpinia Laudanum Institute of Phytopharmaceutical Sciences AG
Representantes
Frank W. Compagni Morriss O'Bryant Compagni Cannon, PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Nutritional supplements for medical use; medicinesparticularly phytopharmaceutical productspharmaceutical preparations for treating irritable bowel syndromeconstipationdiarrhoeainflammatory bowel diseasecoeliac diseaseintolerance to FODMAPs (fermentable oligosaccharidesdisaccharidesmonosaccharides and polyols); active plant agents and plant extracts for medical useplant extracts for pharmaceutical purposes; pharmaceuticalveterinary and sanitary productspharmaceutical preparations for treating irritable bowel syndromeconstipationdiarrhoeainflammatory bowel diseasecoeliac diseaseintolerance to FODMAPs (fermentable oligosaccharidesdisaccharidesmonosaccharides and polyols); dietetic substances in the nature of food and beverages for medical usefood for babies; adjuvants for medical use; amino acids for medical use; anesthetics; analgesics; vermifuges; antibiotics; biological preparations for medical usebiological preparations for treating irritable bowel syndromeconstipationdiarrhoeainflammatory bowel diseasecoeliac diseaseintolerance to FODMAPs (fermentable oligosaccharidesdisaccharidesmonosaccharides and polyols); chemical products for medical usechemical preparations for treating irritable bowel syndromeconstipationdiarrhoeainflammatory bowel diseasecoeliac diseaseintolerance to FODMAPs (fermentable oligosaccharidesdisaccharidesmonosaccharides and polyols); chemical reagents for medical or veterinary use; chemico-pharmaceutical productschemical-pharmaceutical preparations for treating irritable bowel syndromeconstipationdiarrhoeainflammatory bowel diseasecoeliac diseaseintolerance to FODMAPs (fermentable oligosaccharidesdisaccharidesmonosaccharides and polyols); ferments for pharmaceutical use; hormones for medical use; medical infusions for treating irritable bowel syndromeconstipationdiarrhoeainflammatory bowel diseasecoeliac diseaseintolerance to FODMAPs (fermentable oligosaccharidesdisaccharidesmonosaccharides and polyols); medicines for dental usemedicines for treating dentalirritable bowel syndromeconstipationdiarrhoeainflammatory bowel diseasecoeliac diseaseintolerance to FODMAPs (fermentable oligosaccharidesdisaccharidesmonosaccharides and polyols); medicines for human medicinepharmaceutical preparations for treating irritable bowel syndromeconstipationdiarrhoeainflammatory bowel diseasecoeliac diseaseintolerance to FODMAPs (fermentable oligosaccharidesdisaccharidesmonosaccharides and polyols); radiological contrast substances for medical use; steroids
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
26/01/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/06/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
15/05/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
30/04/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
29/04/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
26/04/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
26/01/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/11/2020
PUBO
PUBLISHED FOR OPPOSITION
10/11/2020
GPNX
NOTIFICATION PROCESSED BY IB
08/11/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
21/10/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
21/10/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/10/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/10/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
06/10/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/10/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
06/10/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/09/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/09/2020
RFNT
REFUSAL PROCESSED BY IB
10/04/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
24/03/2020
RFRR
REFUSAL PROCESSED BY MPU
24/03/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/03/2020
CNRT
NON-FINAL ACTION WRITTEN
03/03/2020
DOCK
ASSIGNED TO EXAMINER
25/02/2020
MAFR
APPLICATION FILING RECEIPT MAILED
14/01/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/01/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/01/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ACAZEN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.